Global Metastatic Ovarian Cancer Drug Market Survey and Trend Research 2018

September 2018 | 70 pages | ID: G02A749A8E4EN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Adgero Biopharmaceuticals Inc, Cellceutix Corporation, Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., Millennium Pharmaceuticals Inc, Millennium Pharmaceuticals Inc, MolMed S.p.A., Natco Pharma Limited, Northwest Biotherapeutics, Inc., Pfizer Inc., Richter Gedeon Nyrt., Sumitomo Dainippon Pharma Co., Ltd., VG Life Sciences, Inc. etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Metastatic Ovarian Cancer Drug Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 METASTATIC OVARIAN CANCER DRUG MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Adgero Biopharmaceuticals Inc (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Cellceutix Corporation (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 Eisai Co., Ltd. (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 F. Hoffmann-La Roche Ltd. (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Millennium Pharmaceuticals Inc (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Millennium Pharmaceuticals Inc (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 MolMed S.p.A. (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Natco Pharma Limited (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Northwest Biotherapeutics, Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Pfizer Inc. (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Richter Gedeon Nyrt. (Company Overview, Sales Data etc.)
4.12 Sumitomo Dainippon Pharma Co., Ltd. (Company Overview, Sales Data etc.)
4.13 VG Life Sciences, Inc. (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Metastatic Ovarian Cancer Drug Market 2012-2017, by Type, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market Forecast 2018-2023, by Type, in USD Million
Table Adgero Biopharmaceuticals Inc Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Adgero Biopharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
Table Cellceutix Corporation Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Cellceutix Corporation (Sales Revenue, Cost, Gross Margin)
Table Eisai Co., Ltd. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Eisai Co., Ltd. (Sales Revenue, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Cost, Gross Margin)
Table Millennium Pharmaceuticals Inc Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Millennium Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
Table Millennium Pharmaceuticals Inc Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Millennium Pharmaceuticals Inc (Sales Revenue, Cost, Gross Margin)
Table MolMed S.p.A. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of MolMed S.p.A. (Sales Revenue, Cost, Gross Margin)
Table Natco Pharma Limited Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Natco Pharma Limited (Sales Revenue, Cost, Gross Margin)
Table Northwest Biotherapeutics, Inc. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Northwest Biotherapeutics, Inc. (Sales Revenue, Cost, Gross Margin)
Table Pfizer Inc. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Pfizer Inc. (Sales Revenue, Cost, Gross Margin)
Table Richter Gedeon Nyrt. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Richter Gedeon Nyrt. (Sales Revenue, Cost, Gross Margin)
Table Sumitomo Dainippon Pharma Co., Ltd. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of Sumitomo Dainippon Pharma Co., Ltd. (Sales Revenue, Cost, Gross Margin)
Table VG Life Sciences, Inc. Overview List
Table Metastatic Ovarian Cancer Drug Business Operation of VG Life Sciences, Inc. (Sales Revenue, Cost, Gross Margin)
Table Global Metastatic Ovarian Cancer Drug Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Metastatic Ovarian Cancer Drug Sales Revenue Share, by Companies, in USD Million
Table Metastatic Ovarian Cancer Drug Demand 2012-2017, by Application, in USD Million
Table Metastatic Ovarian Cancer Drug Demand Forecast 2018-2023, by Application, in USD Million
Table Global Metastatic Ovarian Cancer Drug Market 2012-2017, by Region, in USD Million
Table Metastatic Ovarian Cancer Drug Market Forecast 2018-2023, by Region, in USD Million

List Of Figures

LIST OF FIGURES

Figure Metastatic Ovarian Cancer Drug Industry Chain Structure
Figure Global Metastatic Ovarian Cancer Drug Market Growth 2012-2017, by Type, in USD Million
Figure Global Metastatic Ovarian Cancer Drug Sales Revenue Share, by Companies in 2017, in USD Million
Figure Production Development by Region
Figure Sales List by Region